Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Virulizin plus Gemcitabine in Pancreatic Cancer
NCT00040092Phase 3Completed
- Sponsor
- Aptose Biosciences Inc.
- Start
- Jul 2002
- Primary completion
- Jul 2005
- Modality
- Recombinant Proteins and Enzymes
01
Overview
A Phase 3 trial of virulizin in pancreatic cancer (PC), sponsored by Aptose Biosciences Inc.. Started Jul 2002; status: completed.
02
Drugs
virulizin
03
Conditions
pancreatic cancer (PC)
Beyond the preview
Go deeper on NCT00040092.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00040092.